Form D · Biotechnology
Biowise Capital II, LLC
Dallas, TX · CIK 0001844785
Offering snapshot reported Nov 15, 2023 · SEC filing
- Reported sold
- $1.1M Offering amount: $10M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Mar 1, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 14
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 15, 2023 | Amendment | $1,100,000 | No comparison | 14 | SEC filing |
| Feb 8, 2021 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-388670
Source: Form D, filed Nov 15, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Amir Baluch | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Crescent Court, #700
Dallas, TX, 75201
Dallas, TX, 75201